TheneweActros600.CHARGEDTOCHAngE.THENEWeACTROS600.Anewchapterinhaulage:TheeActros600is“chargedtochange”,makingittheheartofanintegratedsolutionforthefuture’stransportcompanies–all-electric,susta...
时间:2024-12-02 11:45栏目:汽车
证券研究报告破茧——2025年医药生物行业年度投资策略行业评级：看好2024年11月19日分析师孙建吴天昊郭双喜王帅司清蕊邮箱sunjian@stocke.com.cnwutianhao@stocke.com.cnguoshuangxi@stocke.com.cnwangshuai1@sto...
时间:2024-11-27 09:41栏目:综合其他
2ContentsIntroduction5UsingAIforauditing/auditingAI7AIinauditing:enhancingcapabilities7AuditingAI:ensuringintegrityandeffectiveness8Goalsandobjectives10Goal1:improveoperationalefficiencyinauditthro...
时间:2024-11-21 21:18栏目:综合其他
全球保险业报告:展望亚洲财险业的未来亚洲财险业已行至十字路口，面临重要抉择。采取双轨策略有望帮助亚洲财险业克服障碍、抓住机遇。本报告由HenrideComblesdeNayves,BernhardKotanko,AngatSandhu和KazuakiTakem...
时间:2024-11-17 14:27栏目:综合其他
证券研究报告·医药行业研究·创新药系列双抗系列报告之三：TCE，不止血液瘤贺菊颖袁清慧研究助理：赵旭zhaoxu1@csc.com.cnhejuying@csc.com.cnyuanqinghui@csc.com.cnSAC执证编号：S1440517050001SAC执证编号：S...
时间:2024-11-01 11:31栏目:综合其他
证券研究报告·医药行业研究·创新药系列双抗系列报告之二：二代IO药物，后PD-1/PD-L1时代的重要投资机会贺菊颖袁清慧研究助理：赵旭zhaoxu1@csc.com.cnhejuying@csc.com.cnyuanqinghui@csc.com.cnSAC执证编号：S...
时间:2024-11-01 11:31栏目:综合其他
5October202412:54PMSGTAsia-PacificPortfolioStrategyChinachangesthegameWeraiseChinatooverweightandincreaseourMXAPJindextargetonhigherTimothyMoe,CFAearningsandvaluations.Wemakeseveralsectorallocation...
时间:2024-10-21 09:24栏目:综合其他
DearChineseReaders,Thesebooksarepracticalguidesonhowtothink.Myfathersaid“youcannotdigaholeinadifferentplacebydiggingthesameholedeeper”.Wehavelearnedtodigholesusinglogicandanalysis.Thisisnecessary...
时间:2024-09-25 13:04栏目:综合其他
DearChineseReaders,Thesebooksarepracticalguidesonhowtothink.Myfathersaid“youcannotdigaholeinadifferentplacebydiggingthesameholedeeper”.Wehavelearnedtodigholesusinglogicandanalysis.Thisisnecessary...
时间:2024-09-25 13:04栏目:综合其他
DearChineseReaders,Thesebooksarepracticalguidesonhowtothink.Myfathersaid“youcannotdigaholeinadifferentplacebydiggingthesameholedeeper”.Wehavelearnedtodigholesusinglogicandanalysis.Thisisnecessary...
时间:2024-09-25 13:04栏目:综合其他
